Management of the urethra in urothelial bladder cancer
- PMID: 20019987
- PMCID: PMC2792442
- DOI: 10.5489/cuaj.1198
Management of the urethra in urothelial bladder cancer
Abstract
The standard of care in the management of invasive urothelial cancer of the bladder is radical cystectomy and pelvic lymphadenectomy. Although uncommon, recurrence of disease in the retained urethra following cystectomy carries a poor prognosis. The need for assessment of risk of recurrence is greater now than ever with wider adoption of orthotopic bladder substitution. This review will address the contemporary management of the urethra following cystectomy for urothelial cancer.
References
-
- Clark PE, Hall MC. Contemporary management of the urethra in patients after radical cystectomy for bladder cancer. Urol Clin North Am. 2005;32:199–206. - PubMed
-
- Schellhammer PF, Whitemore WF., Jr Transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer. J Urol. 1976;115:56–60. - PubMed
-
- Tobisu K, Tanaka Y, Mizutani T, et al. Transitional cell carcinoma of the urethra in men following cystectomy for bladder cancer: multivariate analysis for risk factors J Urol 19911461551–3.discussion 1553–4. - PubMed
-
- Tobisu K, Kanai Y, Sakamoto M, et al. Involvement of the anterior urethra in male patients with transitional cell-carcinoma of the bladder undergoing radical cystectomy with simultaneous urethrectomy. Jpn J Clin Oncol. 1997;27:406–9. - PubMed
-
- Stein JP, Penson DF, Wu SD, et al. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature J Urol 2007178(3Pt1):756–60. - PubMed
LinkOut - more resources
Full Text Sources